Skip to main content
. 2016 Apr 29;82(1):129–138. doi: 10.1111/bcp.12916

Figure 1.

Figure 1

Patient disposition. PK, pharmacokinetics. *Patients enrolled at one site were excluded because the validity of study conduct was not established. (The vast majority of pharmacokinetic profiles from the site were contradictory to the known pharmacokinetic characteristics for rituximab.)